(Q42655757)

4 November 2017

Alzheimer's disease drug development pipeline: 2017. (English)

1 reference

4 November 2017

0 references

1

Jeffrey Cummings

1 reference

4 November 2017

Garam Lee

2

1 reference

4 November 2017

Travis Mortsdorf

series ordinal

3

1 reference

4 November 2017

Aaron Ritter

series ordinal

4

1 reference

4 November 2017

Kate Zhong

series ordinal

5

1 reference

4 November 2017

24 May 2017

1 reference

Alzheimer's & dementia (New York, N. Y.)

4 November 2017

1 reference

4 November 2017

3

1 reference

4 November 2017

3

1 reference

4 November 2017

367-384

1 reference

Re-Engineering Alzheimer Clinical Trials: Global Alzheimer's Platform Network

4 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5651419

The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5651419

Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5651419

Drug development in Alzheimer's disease: the path to 2025

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5651419

Toward a New Era of Trust and Transparency in Clinical Trials

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5651419

Trial Reporting in ClinicalTrials.gov - The Final Rule

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5651419

The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5651419

Revolutionizing Alzheimer's disease and clinical trials through biomarkers

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5651419

Future Therapeutics in Alzheimer's Disease: Development Status of BACE Inhibitors.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5651419

New directions for protease inhibitors directed drug discovery

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5651419

The need for thorough phase II studies in medicines development for Alzheimer's disease

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5651419

Alzheimer's disease research in the context of the national plan to address Alzheimer's disease

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5651419

2015 Alzheimer's disease facts and figures

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5651419

Decision-making in product portfolios of pharmaceutical research and development--managing streams of innovation in highly regulated markets

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5651419

β-secretase inhibitor; a promising novel therapeutic drug in Alzheimer's disease

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5651419

Alzheimer's disease drug-development pipeline: few candidates, frequent failures

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5651419

Parallel discovery of Alzheimer's therapeutics

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5651419

Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5651419

Economic analysis of opportunities to accelerate Alzheimer's disease research and development

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5651419

Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5651419

Discovering new treatments for Alzheimer's disease by repurposing approved medications

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5651419

A review: treatment of Alzheimer's disease discovered in repurposed agents

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5651419

Globalization of Alzheimer's disease clinical trials

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5651419

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5651419

Adaptive design clinical trials and trial logistics models in CNS drug development

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5651419

Issues in the registration of clinical trials

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5651419

Merck ends trial of potential Alzheimer's drug verubecestat

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5651419

Solanezumab and the amyloid hypothesis for Alzheimer's disease

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5651419

Repackaging FDA-approved drugs for degenerative diseases: promises and challenges.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5651419

Biomarkers in Alzheimer's disease drug development.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5651419

Partnerships between philanthropy, government and industry are needed to advance drug discovery for neurodegenerative diseases.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5651419

Clinical Trial Registration: A Statement from the International Committee of Medical Journal Editors

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5651419

Alzheimer's drug-development pipeline: 2016.

30 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FJ.TRCI.2017.05.002

Commercializing biomedical research through securitization techniques

7 January 2021

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FJ.TRCI.2017.05.002

10.1016/J.TRCI.2017.05.002

7 January 2021

Identifiers

DOI

1 reference

4 November 2017

1 reference

4 November 2017

PubMed publication ID

29067343

1 reference